Clinical Trial Update: Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of rucaparib in locally advanced or metastatic urothelial carcinoma was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: pharmaand GmbH | Conditions: Bladder Cancer, Urothelial Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2020-10-19